Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Regional Nodal Irradiation in Early-Stage Breast Cancer.

Identifieur interne : 000D59 ( PubMed/Curation ); précédent : 000D58; suivant : 000D60

Regional Nodal Irradiation in Early-Stage Breast Cancer.

Auteurs : Timothy J. Whelan [Canada] ; Ivo A. Olivotto ; Wendy R. Parulekar ; Ida Ackerman ; Boon H. Chua ; Abdenour Nabid ; Katherine A. Vallis ; Julia R. White ; Pierre Rousseau ; Andre Fortin ; Lori J. Pierce ; Lee Manchul ; Susan Chafe ; Maureen C. Nolan ; Peter Craighead ; Julie Bowen ; David R. Mccready ; Kathleen I. Pritchard ; Karen Gelmon ; Yvonne Murray ; Judy-Anne W. Chapman ; Bingshu E. Chen ; Mark N. Levine

Source :

RBID : pubmed:26200977

Descripteurs français

English descriptors

Abstract

Most women with breast cancer who undergo breast-conserving surgery receive whole-breast irradiation. We examined whether the addition of regional nodal irradiation to whole-breast irradiation improved outcomes.

DOI: 10.1056/NEJMoa1415340
PubMed: 26200977

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:26200977

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Regional Nodal Irradiation in Early-Stage Breast Cancer.</title>
<author>
<name sortKey="Whelan, Timothy J" sort="Whelan, Timothy J" uniqKey="Whelan T" first="Timothy J" last="Whelan">Timothy J. Whelan</name>
<affiliation wicri:level="4">
<nlm:affiliation>From the Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON (T.J.W., M.N.L.), Tom Baker Cancer Centre, Calgary, AB (I.A.O., P.C.), BC Cancer Agency-Vancouver Island Centre, Victoria, BC (I.A.O.), Queen's University and NCIC Clinical Trials Group, Kingston, ON (W.R.P., Y.M., J.-A.W.C., B.E.C.), University of Toronto and Sunnybrook Odette Cancer Centre, Toronto (I.A., K.I.P.), Centre Universitaire de Sherbrooke at Fleurimont Hospital, Sherbrooke, QC (A.N.), Université de Montréal, Montreal (P.R.), Laval University and L'Hôtel-Dieu de Québec, Quebec, QC (A.F.), Princess Margaret Hospital, Toronto (L.M., D.R.M.), Cross Cancer Institute, Edmonton, AB (S.C.), Nova Scotia Cancer Centre, Halifax (M.C.N), Northeastern Ontario Regional Cancer Centre, Sudbury (J.B.), and BC Cancer Agency-Vancouver Centre, Vancouver, BC (K.G.) - all in Canada; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.H.C.); Cancer Research UK-Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom (K.A.V.); Ohio State University Wexner Medical Center, Columbus (J.R.W.); and the University of Michigan Comprehensive Cancer Center, Ann Arbor (L.J.P.).</nlm:affiliation>
<orgName type="university">Université McMaster</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Olivotto, Ivo A" sort="Olivotto, Ivo A" uniqKey="Olivotto I" first="Ivo A" last="Olivotto">Ivo A. Olivotto</name>
</author>
<author>
<name sortKey="Parulekar, Wendy R" sort="Parulekar, Wendy R" uniqKey="Parulekar W" first="Wendy R" last="Parulekar">Wendy R. Parulekar</name>
</author>
<author>
<name sortKey="Ackerman, Ida" sort="Ackerman, Ida" uniqKey="Ackerman I" first="Ida" last="Ackerman">Ida Ackerman</name>
</author>
<author>
<name sortKey="Chua, Boon H" sort="Chua, Boon H" uniqKey="Chua B" first="Boon H" last="Chua">Boon H. Chua</name>
</author>
<author>
<name sortKey="Nabid, Abdenour" sort="Nabid, Abdenour" uniqKey="Nabid A" first="Abdenour" last="Nabid">Abdenour Nabid</name>
</author>
<author>
<name sortKey="Vallis, Katherine A" sort="Vallis, Katherine A" uniqKey="Vallis K" first="Katherine A" last="Vallis">Katherine A. Vallis</name>
</author>
<author>
<name sortKey="White, Julia R" sort="White, Julia R" uniqKey="White J" first="Julia R" last="White">Julia R. White</name>
</author>
<author>
<name sortKey="Rousseau, Pierre" sort="Rousseau, Pierre" uniqKey="Rousseau P" first="Pierre" last="Rousseau">Pierre Rousseau</name>
</author>
<author>
<name sortKey="Fortin, Andre" sort="Fortin, Andre" uniqKey="Fortin A" first="Andre" last="Fortin">Andre Fortin</name>
</author>
<author>
<name sortKey="Pierce, Lori J" sort="Pierce, Lori J" uniqKey="Pierce L" first="Lori J" last="Pierce">Lori J. Pierce</name>
</author>
<author>
<name sortKey="Manchul, Lee" sort="Manchul, Lee" uniqKey="Manchul L" first="Lee" last="Manchul">Lee Manchul</name>
</author>
<author>
<name sortKey="Chafe, Susan" sort="Chafe, Susan" uniqKey="Chafe S" first="Susan" last="Chafe">Susan Chafe</name>
</author>
<author>
<name sortKey="Nolan, Maureen C" sort="Nolan, Maureen C" uniqKey="Nolan M" first="Maureen C" last="Nolan">Maureen C. Nolan</name>
</author>
<author>
<name sortKey="Craighead, Peter" sort="Craighead, Peter" uniqKey="Craighead P" first="Peter" last="Craighead">Peter Craighead</name>
</author>
<author>
<name sortKey="Bowen, Julie" sort="Bowen, Julie" uniqKey="Bowen J" first="Julie" last="Bowen">Julie Bowen</name>
</author>
<author>
<name sortKey="Mccready, David R" sort="Mccready, David R" uniqKey="Mccready D" first="David R" last="Mccready">David R. Mccready</name>
</author>
<author>
<name sortKey="Pritchard, Kathleen I" sort="Pritchard, Kathleen I" uniqKey="Pritchard K" first="Kathleen I" last="Pritchard">Kathleen I. Pritchard</name>
</author>
<author>
<name sortKey="Gelmon, Karen" sort="Gelmon, Karen" uniqKey="Gelmon K" first="Karen" last="Gelmon">Karen Gelmon</name>
</author>
<author>
<name sortKey="Murray, Yvonne" sort="Murray, Yvonne" uniqKey="Murray Y" first="Yvonne" last="Murray">Yvonne Murray</name>
</author>
<author>
<name sortKey="Chapman, Judy Anne W" sort="Chapman, Judy Anne W" uniqKey="Chapman J" first="Judy-Anne W" last="Chapman">Judy-Anne W. Chapman</name>
</author>
<author>
<name sortKey="Chen, Bingshu E" sort="Chen, Bingshu E" uniqKey="Chen B" first="Bingshu E" last="Chen">Bingshu E. Chen</name>
</author>
<author>
<name sortKey="Levine, Mark N" sort="Levine, Mark N" uniqKey="Levine M" first="Mark N" last="Levine">Mark N. Levine</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26200977</idno>
<idno type="pmid">26200977</idno>
<idno type="doi">10.1056/NEJMoa1415340</idno>
<idno type="wicri:Area/PubMed/Corpus">000D59</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D59</idno>
<idno type="wicri:Area/PubMed/Curation">000D59</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D59</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Regional Nodal Irradiation in Early-Stage Breast Cancer.</title>
<author>
<name sortKey="Whelan, Timothy J" sort="Whelan, Timothy J" uniqKey="Whelan T" first="Timothy J" last="Whelan">Timothy J. Whelan</name>
<affiliation wicri:level="4">
<nlm:affiliation>From the Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON (T.J.W., M.N.L.), Tom Baker Cancer Centre, Calgary, AB (I.A.O., P.C.), BC Cancer Agency-Vancouver Island Centre, Victoria, BC (I.A.O.), Queen's University and NCIC Clinical Trials Group, Kingston, ON (W.R.P., Y.M., J.-A.W.C., B.E.C.), University of Toronto and Sunnybrook Odette Cancer Centre, Toronto (I.A., K.I.P.), Centre Universitaire de Sherbrooke at Fleurimont Hospital, Sherbrooke, QC (A.N.), Université de Montréal, Montreal (P.R.), Laval University and L'Hôtel-Dieu de Québec, Quebec, QC (A.F.), Princess Margaret Hospital, Toronto (L.M., D.R.M.), Cross Cancer Institute, Edmonton, AB (S.C.), Nova Scotia Cancer Centre, Halifax (M.C.N), Northeastern Ontario Regional Cancer Centre, Sudbury (J.B.), and BC Cancer Agency-Vancouver Centre, Vancouver, BC (K.G.) - all in Canada; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.H.C.); Cancer Research UK-Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom (K.A.V.); Ohio State University Wexner Medical Center, Columbus (J.R.W.); and the University of Michigan Comprehensive Cancer Center, Ann Arbor (L.J.P.).</nlm:affiliation>
<orgName type="university">Université McMaster</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Hamilton (Ontario)</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Olivotto, Ivo A" sort="Olivotto, Ivo A" uniqKey="Olivotto I" first="Ivo A" last="Olivotto">Ivo A. Olivotto</name>
</author>
<author>
<name sortKey="Parulekar, Wendy R" sort="Parulekar, Wendy R" uniqKey="Parulekar W" first="Wendy R" last="Parulekar">Wendy R. Parulekar</name>
</author>
<author>
<name sortKey="Ackerman, Ida" sort="Ackerman, Ida" uniqKey="Ackerman I" first="Ida" last="Ackerman">Ida Ackerman</name>
</author>
<author>
<name sortKey="Chua, Boon H" sort="Chua, Boon H" uniqKey="Chua B" first="Boon H" last="Chua">Boon H. Chua</name>
</author>
<author>
<name sortKey="Nabid, Abdenour" sort="Nabid, Abdenour" uniqKey="Nabid A" first="Abdenour" last="Nabid">Abdenour Nabid</name>
</author>
<author>
<name sortKey="Vallis, Katherine A" sort="Vallis, Katherine A" uniqKey="Vallis K" first="Katherine A" last="Vallis">Katherine A. Vallis</name>
</author>
<author>
<name sortKey="White, Julia R" sort="White, Julia R" uniqKey="White J" first="Julia R" last="White">Julia R. White</name>
</author>
<author>
<name sortKey="Rousseau, Pierre" sort="Rousseau, Pierre" uniqKey="Rousseau P" first="Pierre" last="Rousseau">Pierre Rousseau</name>
</author>
<author>
<name sortKey="Fortin, Andre" sort="Fortin, Andre" uniqKey="Fortin A" first="Andre" last="Fortin">Andre Fortin</name>
</author>
<author>
<name sortKey="Pierce, Lori J" sort="Pierce, Lori J" uniqKey="Pierce L" first="Lori J" last="Pierce">Lori J. Pierce</name>
</author>
<author>
<name sortKey="Manchul, Lee" sort="Manchul, Lee" uniqKey="Manchul L" first="Lee" last="Manchul">Lee Manchul</name>
</author>
<author>
<name sortKey="Chafe, Susan" sort="Chafe, Susan" uniqKey="Chafe S" first="Susan" last="Chafe">Susan Chafe</name>
</author>
<author>
<name sortKey="Nolan, Maureen C" sort="Nolan, Maureen C" uniqKey="Nolan M" first="Maureen C" last="Nolan">Maureen C. Nolan</name>
</author>
<author>
<name sortKey="Craighead, Peter" sort="Craighead, Peter" uniqKey="Craighead P" first="Peter" last="Craighead">Peter Craighead</name>
</author>
<author>
<name sortKey="Bowen, Julie" sort="Bowen, Julie" uniqKey="Bowen J" first="Julie" last="Bowen">Julie Bowen</name>
</author>
<author>
<name sortKey="Mccready, David R" sort="Mccready, David R" uniqKey="Mccready D" first="David R" last="Mccready">David R. Mccready</name>
</author>
<author>
<name sortKey="Pritchard, Kathleen I" sort="Pritchard, Kathleen I" uniqKey="Pritchard K" first="Kathleen I" last="Pritchard">Kathleen I. Pritchard</name>
</author>
<author>
<name sortKey="Gelmon, Karen" sort="Gelmon, Karen" uniqKey="Gelmon K" first="Karen" last="Gelmon">Karen Gelmon</name>
</author>
<author>
<name sortKey="Murray, Yvonne" sort="Murray, Yvonne" uniqKey="Murray Y" first="Yvonne" last="Murray">Yvonne Murray</name>
</author>
<author>
<name sortKey="Chapman, Judy Anne W" sort="Chapman, Judy Anne W" uniqKey="Chapman J" first="Judy-Anne W" last="Chapman">Judy-Anne W. Chapman</name>
</author>
<author>
<name sortKey="Chen, Bingshu E" sort="Chen, Bingshu E" uniqKey="Chen B" first="Bingshu E" last="Chen">Bingshu E. Chen</name>
</author>
<author>
<name sortKey="Levine, Mark N" sort="Levine, Mark N" uniqKey="Levine M" first="Mark N" last="Levine">Mark N. Levine</name>
</author>
</analytic>
<series>
<title level="j">The New England journal of medicine</title>
<idno type="eISSN">1533-4406</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antineoplastic Agents (therapeutic use)</term>
<term>Breast Neoplasms (mortality)</term>
<term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Lymphatic Metastasis (radiotherapy)</term>
<term>Mastectomy, Segmental</term>
<term>Middle Aged</term>
<term>Neoplasm Recurrence, Local (prevention & control)</term>
<term>Neoplasm Staging</term>
<term>Radiation Dosage</term>
<term>Radiotherapy (adverse effects)</term>
<term>Risk</term>
<term>Sentinel Lymph Node Biopsy</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Antinéoplasiques (usage thérapeutique)</term>
<term>Association thérapeutique</term>
<term>Biopsie de noeud lymphatique sentinelle</term>
<term>Dose de radiation</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mastectomie partielle</term>
<term>Métastase lymphatique (radiothérapie)</term>
<term>Radiothérapie (effets indésirables)</term>
<term>Risque</term>
<term>Récidive tumorale locale ()</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (mortalité)</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antineoplastic Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en">
<term>Radiotherapy</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr">
<term>Radiothérapie</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr">
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Neoplasm Recurrence, Local</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en">
<term>Breast Neoplasms</term>
<term>Lymphatic Metastasis</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr">
<term>Métastase lymphatique</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Antinéoplasiques</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Mastectomy, Segmental</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Radiation Dosage</term>
<term>Risk</term>
<term>Sentinel Lymph Node Biopsy</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analyse de survie</term>
<term>Association thérapeutique</term>
<term>Biopsie de noeud lymphatique sentinelle</term>
<term>Dose de radiation</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mastectomie partielle</term>
<term>Risque</term>
<term>Récidive tumorale locale</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Tumeurs du sein</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Most women with breast cancer who undergo breast-conserving surgery receive whole-breast irradiation. We examined whether the addition of regional nodal irradiation to whole-breast irradiation improved outcomes.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26200977</PMID>
<DateCreated>
<Year>2015</Year>
<Month>07</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted>
<Year>2015</Year>
<Month>08</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised>
<Year>2016</Year>
<Month>12</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">1533-4406</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>373</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2015</Year>
<Month>Jul</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>The New England journal of medicine</Title>
<ISOAbbreviation>N. Engl. J. Med.</ISOAbbreviation>
</Journal>
<ArticleTitle>Regional Nodal Irradiation in Early-Stage Breast Cancer.</ArticleTitle>
<Pagination>
<MedlinePgn>307-16</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1056/NEJMoa1415340</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Most women with breast cancer who undergo breast-conserving surgery receive whole-breast irradiation. We examined whether the addition of regional nodal irradiation to whole-breast irradiation improved outcomes.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We randomly assigned women with node-positive or high-risk node-negative breast cancer who were treated with breast-conserving surgery and adjuvant systemic therapy to undergo either whole-breast irradiation plus regional nodal irradiation (including internal mammary, supraclavicular, and axillary lymph nodes) (nodal-irradiation group) or whole-breast irradiation alone (control group). The primary outcome was overall survival. Secondary outcomes were disease-free survival, isolated locoregional disease-free survival, and distant disease-free survival.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Between March 2000 and February 2007, a total of 1832 women were assigned to the nodal-irradiation group or the control group (916 women in each group). The median follow-up was 9.5 years. At the 10-year follow-up, there was no significant between-group difference in survival, with a rate of 82.8% in the nodal-irradiation group and 81.8% in the control group (hazard ratio, 0.91; 95% confidence interval [CI], 0.72 to 1.13; P=0.38). The rates of disease-free survival were 82.0% in the nodal-irradiation group and 77.0% in the control group (hazard ratio, 0.76; 95% CI, 0.61 to 0.94; P=0.01). Patients in the nodal-irradiation group had higher rates of grade 2 or greater acute pneumonitis (1.2% vs. 0.2%, P=0.01) and lymphedema (8.4% vs. 4.5%, P=0.001).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among women with node-positive or high-risk node-negative breast cancer, the addition of regional nodal irradiation to whole-breast irradiation did not improve overall survival but reduced the rate of breast-cancer recurrence. (Funded by the Canadian Cancer Society Research Institute and others; MA.20 ClinicalTrials.gov number, NCT00005957.).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Whelan</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>From the Department of Oncology, McMaster University, and Juravinski Cancer Centre, Hamilton, ON (T.J.W., M.N.L.), Tom Baker Cancer Centre, Calgary, AB (I.A.O., P.C.), BC Cancer Agency-Vancouver Island Centre, Victoria, BC (I.A.O.), Queen's University and NCIC Clinical Trials Group, Kingston, ON (W.R.P., Y.M., J.-A.W.C., B.E.C.), University of Toronto and Sunnybrook Odette Cancer Centre, Toronto (I.A., K.I.P.), Centre Universitaire de Sherbrooke at Fleurimont Hospital, Sherbrooke, QC (A.N.), Université de Montréal, Montreal (P.R.), Laval University and L'Hôtel-Dieu de Québec, Quebec, QC (A.F.), Princess Margaret Hospital, Toronto (L.M., D.R.M.), Cross Cancer Institute, Edmonton, AB (S.C.), Nova Scotia Cancer Centre, Halifax (M.C.N), Northeastern Ontario Regional Cancer Centre, Sudbury (J.B.), and BC Cancer Agency-Vancouver Centre, Vancouver, BC (K.G.) - all in Canada; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.H.C.); Cancer Research UK-Medical Research Council Oxford Institute for Radiation Oncology, Oxford, United Kingdom (K.A.V.); Ohio State University Wexner Medical Center, Columbus (J.R.W.); and the University of Michigan Comprehensive Cancer Center, Ann Arbor (L.J.P.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Olivotto</LastName>
<ForeName>Ivo A</ForeName>
<Initials>IA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Parulekar</LastName>
<ForeName>Wendy R</ForeName>
<Initials>WR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Ackerman</LastName>
<ForeName>Ida</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chua</LastName>
<ForeName>Boon H</ForeName>
<Initials>BH</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nabid</LastName>
<ForeName>Abdenour</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Vallis</LastName>
<ForeName>Katherine A</ForeName>
<Initials>KA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>White</LastName>
<ForeName>Julia R</ForeName>
<Initials>JR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rousseau</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Fortin</LastName>
<ForeName>Andre</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pierce</LastName>
<ForeName>Lori J</ForeName>
<Initials>LJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Manchul</LastName>
<ForeName>Lee</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chafe</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Nolan</LastName>
<ForeName>Maureen C</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Craighead</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bowen</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McCready</LastName>
<ForeName>David R</ForeName>
<Initials>DR</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Pritchard</LastName>
<ForeName>Kathleen I</ForeName>
<Initials>KI</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gelmon</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Murray</LastName>
<ForeName>Yvonne</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chapman</LastName>
<ForeName>Judy-Anne W</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chen</LastName>
<ForeName>Bingshu E</ForeName>
<Initials>BE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Levine</LastName>
<ForeName>Mark N</ForeName>
<Initials>MN</Initials>
</Author>
<Author ValidYN="Y">
<CollectiveName>MA.20 Study Investigators</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00005957</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U10 CA027057</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01 CA032102</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 CA077202</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA077202</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 CA032102</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>N01 CA027057</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>N Engl J Med</MedlineTA>
<NlmUniqueID>0255562</NlmUniqueID>
<ISSNLinking>0028-4793</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Oncol. 2000;39(3):355-72</RefSource>
<PMID Version="1">10987233</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2010 Apr 1;28(10):1677-83</RefSource>
<PMID Version="1">20065188</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 1985 Mar 14;312(11):665-73</RefSource>
<PMID Version="1">3883167</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Oncol. 2008 Sep;19(9):1553-60</RefSource>
<PMID Version="1">18467318</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2008 Mar 20;26(9):1419-26</RefSource>
<PMID Version="1">18285604</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Breast Cancer Res Treat. 2008 Feb;107(3):379-87</RefSource>
<PMID Version="1">17457670</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2007 Nov 22;357(21):2189-94</RefSource>
<PMID Version="1">18032770</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):365-73</RefSource>
<PMID Version="1">15667954</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 1999 May 15;353(9165):1641-8</RefSource>
<PMID Version="1">10335782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 1997 Oct 2;337(14):956-62</RefSource>
<PMID Version="1">9309100</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 1997 Oct 2;337(14):949-55</RefSource>
<PMID Version="1">9395428</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Natl Cancer Inst. 1996 Nov 20;88(22):1659-64</RefSource>
<PMID Version="1">8931610</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 1993 Jun 3;328(22):1587-91</RefSource>
<PMID Version="1">8387637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int J Radiat Oncol Biol Phys. 1988 Mar;14(3):477-81</RefSource>
<PMID Version="1">3343155</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2015 Jul 23;373(4):317-27</RefSource>
<PMID Version="1">26200978</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2014 Jun 21;383(9935):2127-35</RefSource>
<PMID Version="1">24656685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2010 Apr 1;28(10):1684-91</RefSource>
<PMID Version="1">20194857</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>JAMA. 2011 Feb 9;305(6):569-75</RefSource>
<PMID Version="1">21304082</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Strahlenther Onkol. 2015 Nov;191(11):889-91</RefSource>
<PMID Version="1">26374451</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):46-8</RefSource>
<PMID Version="1">27084624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>BMJ. 2015;351:h4012</RefSource>
<PMID Version="1">26206999</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>N Engl J Med. 2015 Nov 5;373(19):1878-9</RefSource>
<PMID Version="1">26535517</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>N Engl J Med. 2015 Nov 5;373(19):1877-8</RefSource>
<PMID Version="1">26535518</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>Nat Rev Clin Oncol. 2015 Sep;12(9):501</RefSource>
<PMID Version="1">26241938</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn">
<RefSource>N Engl J Med. 2015 Jul 23;373(4):379-81</RefSource>
<PMID Version="1">26200984</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015412" MajorTopicYN="N">Mastectomy, Segmental</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011829" MajorTopicYN="N">Radiation Dosage</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011878" MajorTopicYN="N">Radiotherapy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">NIHMS711757</OtherID>
<OtherID Source="NLM">PMC4556358</OtherID>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Grant</LastName>
<ForeName>Nancy</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kwan</LastName>
<ForeName>Winkle</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leong</LastName>
<ForeName>Carson</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Balkwill</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wilson</LastName>
<ForeName>Don C</ForeName>
<Initials>DC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carolan</LastName>
<ForeName>Hannah</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Goutsouliak</LastName>
<ForeName>Valeri</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tyldesley</LastName>
<ForeName>Scott</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lim</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Weir</LastName>
<ForeName>Lorna</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Aquino-Parsons</LastName>
<ForeName>Christina F</ForeName>
<Initials>CF</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Campbell</LastName>
<ForeName>Gillian</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Keyes</LastName>
<ForeName>Mira</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gelmon</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Olivotto</LastName>
<ForeName>Ivo</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Truong</LastName>
<ForeName>Pauline</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wai</LastName>
<ForeName>Elaine</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kader</LastName>
<ForeName>Hosam</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Blood</LastName>
<ForeName>Paul A</ForeName>
<Initials>PA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alexander</LastName>
<ForeName>Skaria</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Roy</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guay</LastName>
<ForeName>Jean-Pierre</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Del Vecchio</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jolicoeur</LastName>
<ForeName>Marjory</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Methot</LastName>
<ForeName>Francis</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ayllon</LastName>
<ForeName>Jose</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lavertu</LastName>
<ForeName>Sophie</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fortin</LastName>
<ForeName>Marie-Andree</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rousseau</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Germain</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Larochelle-Beland</LastName>
<ForeName>Marie</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vallieres</LastName>
<ForeName>Isabelle</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Blondeau</LastName>
<ForeName>Lucie</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Laverdiere</LastName>
<ForeName>Jacques</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dagnault</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Raymond</LastName>
<ForeName>Paul-Emile</ForeName>
<Initials>PE</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fortin</LastName>
<ForeName>Andre</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Butler</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Akra</LastName>
<ForeName>Mohamed A M</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cooke</LastName>
<ForeName>Andrew L</ForeName>
<Initials>AL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nabid</LastName>
<ForeName>Abdenour</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bujold</LastName>
<ForeName>Rachel</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ballivy</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Prevot</LastName>
<ForeName>Gilles</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chafe</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Severin</LastName>
<ForeName>Diane</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lees</LastName>
<ForeName>Alan</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tankel</LastName>
<ForeName>Keith</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mehta</LastName>
<ForeName>Nirmal</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Abdulkarim</LastName>
<ForeName>Bassam</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Amanie</LastName>
<ForeName>John Oliver</ForeName>
<Initials>JO</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nijjar</LastName>
<ForeName>Tirath</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Greenland</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Basrur</LastName>
<ForeName>Vasanth R</ForeName>
<Initials>VR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gopaul</LastName>
<ForeName>Darindra</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Whelan</LastName>
<ForeName>Timothy J</ForeName>
<Initials>TJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Dayes</LastName>
<ForeName>Ian S</ForeName>
<Initials>IS</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Strang</LastName>
<ForeName>Barbara</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Reiter</LastName>
<ForeName>Harold I</ForeName>
<Initials>HI</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sussman</LastName>
<ForeName>Jonathan</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wright</LastName>
<ForeName>James R</ForeName>
<Initials>JR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Voruganti</LastName>
<ForeName>Sachi M</ForeName>
<Initials>SM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hodson</LastName>
<ForeName>Ian</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McMillan</LastName>
<ForeName>William G</ForeName>
<Initials>WG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Levine</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vujovic</LastName>
<ForeName>Olga</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lock</LastName>
<ForeName>Michael I</ForeName>
<Initials>MI</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>D'Souza</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Perera</LastName>
<ForeName>Francisco</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Read</LastName>
<ForeName>Nancy</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yu</LastName>
<ForeName>Edward</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lambert</LastName>
<ForeName>Christine</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Duclos</LastName>
<ForeName>Marie</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Portelance</LastName>
<ForeName>Lorraine</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>David</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Shenouda</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Melnychuk</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sultanem</LastName>
<ForeName>Khalil</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Giesbrecht</LastName>
<ForeName>Janice</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Shao</LastName>
<ForeName>Richard H F</ForeName>
<Initials>RH</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Findlay</LastName>
<ForeName>Brian</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bowen</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bissett</LastName>
<ForeName>Randall J</ForeName>
<Initials>RJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Want</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Shehata</LastName>
<ForeName>Sarwat</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ackerman</LastName>
<ForeName>Ida</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Paszat</LastName>
<ForeName>Lawrence</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Benk</LastName>
<ForeName>Veronique</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Szumacher</LastName>
<ForeName>Ewa</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tsao</LastName>
<ForeName>May</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pignol</LastName>
<ForeName>Jean-Philippe</ForeName>
<Initials>JP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rakovitch</LastName>
<ForeName>Eileen</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Spayne</LastName>
<ForeName>Jacqueline</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Czarnota</LastName>
<ForeName>Gregory</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wojcicka</LastName>
<ForeName>Anna Maria</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chow</LastName>
<ForeName>Edward L</ForeName>
<Initials>EL</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pritchard</LastName>
<ForeName>Kathleen</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Meng</LastName>
<ForeName>Joanne</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Caudrelier</LastName>
<ForeName>Jean-Michel</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grimard</LastName>
<ForeName>Laval J</ForeName>
<Initials>LJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lochrin</LastName>
<ForeName>Catherine</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nair</LastName>
<ForeName>Bhavani D</ForeName>
<Initials>BD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cross</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rheaume</LastName>
<ForeName>Dorianne</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cwajna</LastName>
<ForeName>Wladyslawa</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rutledge</LastName>
<ForeName>Robert D H</ForeName>
<Initials>RD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Nolan</LastName>
<ForeName>Maureen</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>El-Gayed</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Skarsgard</LastName>
<ForeName>David P</ForeName>
<Initials>DP</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lirette</LastName>
<ForeName>Andree</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rojas</LastName>
<ForeName>Fernando</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leblanc</LastName>
<ForeName>Linda</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Falkson</LastName>
<ForeName>Conrad</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Anthes</LastName>
<ForeName>Margaret L</ForeName>
<Initials>ML</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Craighead</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Trotter</LastName>
<ForeName>Theresa</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mackinnon</LastName>
<ForeName>Jack</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Husain</LastName>
<ForeName>Siraj</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McKinnon</LastName>
<ForeName>Gregory</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vallis</LastName>
<ForeName>Katherine</ForeName>
<Initials>K</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Manchul</LastName>
<ForeName>Lee</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wells</LastName>
<ForeName>Woodrow A</ForeName>
<Initials>WA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fyles</LastName>
<ForeName>Anthony</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Liu</LastName>
<ForeName>Fei-Fei</ForeName>
<Initials>FF</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Levin</LastName>
<ForeName>Wilfred</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cho</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kane</LastName>
<ForeName>Gabrielle</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Koch</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>McCready</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Feigan</LastName>
<ForeName>Malcolm</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Papadatos</LastName>
<ForeName>George</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lonergan</LastName>
<ForeName>Denise</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Peres</LastName>
<ForeName>Helen</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Delaney</LastName>
<ForeName>Geoff</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cox</LastName>
<ForeName>Judith</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bryant</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>O'Brien</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ludbrook</LastName>
<ForeName>Jane</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kumar</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chua</LastName>
<ForeName>Boon</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Blakey</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Phillips</LastName>
<ForeName>Claire</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bishop</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guglani</LastName>
<ForeName>Sam</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Drummond</LastName>
<ForeName>Roslyn</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sexton</LastName>
<ForeName>Maree</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lehman</LastName>
<ForeName>Margot</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Harvey</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gowda</LastName>
<ForeName>Raghu</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Penniment</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carruthers</LastName>
<ForeName>Scott</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Latham</LastName>
<ForeName>Margaret</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Joseph</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Spry</LastName>
<ForeName>Nigel</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Graham</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ahern</LastName>
<ForeName>Verity</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Parda</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Taylor</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Roig</LastName>
<ForeName>Berna</ForeName>
<Initials>B</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Champion</LastName>
<ForeName>Lorraine</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Benda</LastName>
<ForeName>Rashmi</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kasper</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moni</LastName>
<ForeName>Janaki</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bains</LastName>
<ForeName>Yadvindera</ForeName>
<Initials>Y</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rearden</LastName>
<ForeName>Timothy</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Olson</LastName>
<ForeName>Carl</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Schultz</LastName>
<ForeName>Craig</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Berk</LastName>
<ForeName>Lawrence</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Becker</LastName>
<ForeName>Mark</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Leider</LastName>
<ForeName>Peter</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mueller</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>White</LastName>
<ForeName>Julia</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zaren</LastName>
<ForeName>Howard</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Avizonis</LastName>
<ForeName>Vilija</ForeName>
<Initials>V</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Petersen</LastName>
<ForeName>Ivy</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vallow</LastName>
<ForeName>Laura</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tan</LastName>
<ForeName>Winston</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Buskirk</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ridings</LastName>
<ForeName>Jane</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bollinger</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Johnson</LastName>
<ForeName>Nina</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Daconceicao</LastName>
<ForeName>Alberto</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Casey</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kuettel</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yap</LastName>
<ForeName>Johnny</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Saito</LastName>
<ForeName>Naoyuki</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pruitt</LastName>
<ForeName>David</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jafar</LastName>
<ForeName>Salam</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gemer</LastName>
<ForeName>Linda</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Lakomy</LastName>
<ForeName>Dale</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Herman</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Stinson</LastName>
<ForeName>Susan</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Chmura</LastName>
<ForeName>Steven</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pierce</LastName>
<ForeName>Lori</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Streeter</LastName>
<ForeName>Oscar</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Waylene</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Yao</LastName>
<ForeName>Michelle</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Soriano</LastName>
<ForeName>Julie</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Clapper</LastName>
<ForeName>Wingate</ForeName>
<Initials>W</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jones</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Richardson</LastName>
<ForeName>James</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Forman</LastName>
<ForeName>Jeffrey</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kim</LastName>
<ForeName>Harry</ForeName>
<Initials>H</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Washington</LastName>
<ForeName>Tara</ForeName>
<Initials>T</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>7</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>7</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>8</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26200977</ArticleId>
<ArticleId IdType="doi">10.1056/NEJMoa1415340</ArticleId>
<ArticleId IdType="pmc">PMC4556358</ArticleId>
<ArticleId IdType="mid">NIHMS711757</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D59 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000D59 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:26200977
   |texte=   Regional Nodal Irradiation in Early-Stage Breast Cancer.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:26200977" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024